
Gims S. Philippe
Examiner (ID: 298, Phone: (571)272-7336 , Office: P/2489 )
| Most Active Art Unit | 2424 |
| Art Unit(s) | 2613, 2713, 2424, 2482, 2489, 2621, 2485 |
| Total Applications | 1805 |
| Issued Applications | 1438 |
| Pending Applications | 169 |
| Abandoned Applications | 234 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19472639
[patent_doc_number] => 12102702
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => Personal care compositions
[patent_app_type] => utility
[patent_app_number] => 17/743262
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12615
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743262
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/743262 | Personal care compositions | May 11, 2022 | Issued |
Array
(
[id] => 18192667
[patent_doc_number] => 20230046186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => Process for the preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof
[patent_app_type] => utility
[patent_app_number] => 17/739862
[patent_app_country] => US
[patent_app_date] => 2022-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8052
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17739862
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/739862 | Process for the preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof | May 8, 2022 | Abandoned |
Array
(
[id] => 17805673
[patent_doc_number] => 20220257508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
[patent_app_type] => utility
[patent_app_number] => 17/736291
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736291
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736291 | SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN | May 3, 2022 | Abandoned |
Array
(
[id] => 17988718
[patent_doc_number] => 20220354755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => SPRAYABLE COSMETIC COMPOSITION COMPRISING POLYGLYCEROL ESTERS
[patent_app_type] => utility
[patent_app_number] => 17/735667
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735667
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/735667 | SPRAYABLE COSMETIC COMPOSITION COMPRISING POLYGLYCEROL ESTERS | May 2, 2022 | Abandoned |
Array
(
[id] => 20432482
[patent_doc_number] => 12502339
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-23
[patent_title] => Foam compositions
[patent_app_type] => utility
[patent_app_number] => 17/734188
[patent_app_country] => US
[patent_app_date] => 2022-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 3907
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17734188
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/734188 | Foam compositions | May 1, 2022 | Issued |
Array
(
[id] => 17988717
[patent_doc_number] => 20220354754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => FOAM COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/734193
[patent_app_country] => US
[patent_app_date] => 2022-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17734193
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/734193 | FOAM COMPOSITIONS | May 1, 2022 | Abandoned |
Array
(
[id] => 18411992
[patent_doc_number] => 11666519
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-06
[patent_title] => Personal care compositions with cystine
[patent_app_type] => utility
[patent_app_number] => 17/730500
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9706
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730500
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/730500 | Personal care compositions with cystine | Apr 26, 2022 | Issued |
Array
(
[id] => 17790291
[patent_doc_number] => 20220249382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => COMPOSITIONS COMPRISING INDIGO AND/OR AN INDIGO DERIVATIVE AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/727510
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19701
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17727510
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/727510 | COMPOSITIONS COMPRISING INDIGO AND/OR AN INDIGO DERIVATIVE AND METHODS OF USE THEREOF | Apr 21, 2022 | Abandoned |
Array
(
[id] => 17774848
[patent_doc_number] => 20220241197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
[patent_app_type] => utility
[patent_app_number] => 17/725923
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17725923
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/725923 | Suspensions and diluents for metronidazole and baclofen | Apr 20, 2022 | Issued |
Array
(
[id] => 17759814
[patent_doc_number] => 20220233426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => Gel Texturizer Base for Cosmetics
[patent_app_type] => utility
[patent_app_number] => 17/719283
[patent_app_country] => US
[patent_app_date] => 2022-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25951
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17719283
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/719283 | Gel texturizer base for cosmetics | Apr 11, 2022 | Issued |
Array
(
[id] => 19201362
[patent_doc_number] => 20240173261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => FORMULATION COMPRISING CERALASERTIB
[patent_app_type] => utility
[patent_app_number] => 18/552014
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6533
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552014
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552014 | FORMULATION COMPRISING CERALASERTIB | Mar 20, 2022 | Pending |
Array
(
[id] => 18869888
[patent_doc_number] => 11857668
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-01-02
[patent_title] => Underarm toner
[patent_app_type] => utility
[patent_app_number] => 17/686198
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1178
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17686198
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/686198 | Underarm toner | Mar 2, 2022 | Issued |
Array
(
[id] => 17759874
[patent_doc_number] => 20220233486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => RESPIRATORY TRACT DELIVERY OF LEVODOPA AND DOPA DECARBOXYLASE INHIBITOR FOR TREATMENT OF PARKINSON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/682033
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17682033
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/682033 | Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's disease | Feb 27, 2022 | Issued |
Array
(
[id] => 17836397
[patent_doc_number] => 20220273702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => HYDROGEN SULFIDE AND NITRIC OXIDE THERAPY FOR COVID-19 INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/681705
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14013
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681705
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/681705 | HYDROGEN SULFIDE AND NITRIC OXIDE THERAPY FOR COVID-19 INFECTION | Feb 24, 2022 | Abandoned |
Array
(
[id] => 17609817
[patent_doc_number] => 20220152096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => IODINE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/665313
[patent_app_country] => US
[patent_app_date] => 2022-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17665313
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/665313 | Iodine compositions | Feb 3, 2022 | Issued |
Array
(
[id] => 19018857
[patent_doc_number] => 20240075028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING TADALAFIL OR PHARMACEUTICALLLY ACCEPTABLE SALT THEREOF AND DUTASTERIDE OR PHARMACEUTICALLLY ACCEPTABLE SALT THEREOF EXHIBITING NOVEL DISSOLUTION RATE
[patent_app_type] => utility
[patent_app_number] => 18/269379
[patent_app_country] => US
[patent_app_date] => 2021-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18269379
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/269379 | PHARMACEUTICAL COMPOSITION COMPRISING TADALAFIL OR PHARMACEUTICALLLY ACCEPTABLE SALT THEREOF AND DUTASTERIDE OR PHARMACEUTICALLLY ACCEPTABLE SALT THEREOF EXHIBITING NOVEL DISSOLUTION RATE | Dec 29, 2021 | Pending |
Array
(
[id] => 18752269
[patent_doc_number] => 20230355487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => Compositions and Related Methods
[patent_app_type] => utility
[patent_app_number] => 17/632182
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17632182
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/632182 | Compositions and Related Methods | Dec 16, 2021 | Pending |
Array
(
[id] => 19290468
[patent_doc_number] => 12029807
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => No-rinse makeup removal composition
[patent_app_type] => utility
[patent_app_number] => 17/553425
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9566
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17553425
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/553425 | No-rinse makeup removal composition | Dec 15, 2021 | Issued |
Array
(
[id] => 17988088
[patent_doc_number] => 20220354125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => METHOD FOR USING MUSTARD MEAL OR AN EXTRACT THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/549491
[patent_app_country] => US
[patent_app_date] => 2021-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22653
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17549491
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/549491 | METHOD FOR USING MUSTARD MEAL OR AN EXTRACT THEREOF | Dec 12, 2021 | Abandoned |
Array
(
[id] => 17670774
[patent_doc_number] => 20220183941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => SILICONE OIL-FREE ANTIPERSPIRANTS
[patent_app_type] => utility
[patent_app_number] => 17/547045
[patent_app_country] => US
[patent_app_date] => 2021-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4585
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17547045
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/547045 | SILICONE OIL-FREE ANTIPERSPIRANTS | Dec 8, 2021 | Abandoned |